SCHEMBL4350812

SCHEMBL4350812

COc1ccc(-c2c[nH]c3ncnc(N)c23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.57
PPARG P37231 1/20 0.51
KMT2A Q03164 1/20 0.51
NR2E3 Q9Y5X4 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
SRC P12931 5/20 0.50
ABL1 P00519 3/20 0.50
EGFR P00533 3/20 0.50
ABL2 P42684 2/20 0.50
BRAF P15056 1/20 0.50
TNNI3K Q59H18 1/20 0.50
TEK Q02763 2/20 0.49
LCK P06239 2/20 0.49
KIT P10721 2/20 0.48
LIMK1 P53667 2/20 0.47
JAK2 O60674 1/20 0.47
JAK3 P52333 1/20 0.47
MAP4K4 O95819 2/20 0.47
CDC7 O00311 1/20 0.47
PLK4 O00444 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2257351 0.84 MAPT (0.56) KDRKMT2ABRAFTNNI3KLCK
SCHEMBL7013879 0.83 LRRK2 (0.65) KDRSRCABL1EGFRABL2
SCHEMBL1896766 0.83 STK3 (0.58) KDRPPARGKMT2ANR2E3NCOR2
SCHEMBL410257 0.83 NUDT14 (0.55) KDRKMT2ASRCEGFRTEK
SCHEMBL29552165 0.83 NUDT14 (0.55) KDRKMT2ASRCEGFRTEK
SCHEMBL24710755 0.83 LRRK2 (0.51) KDRLCKKITLIMK1JAK2
SCHEMBL2073031 0.82 LCK (0.54) KDRSRCTEKLCKLIMK1
Bromide SCHEMBL6865619 0.82 NUDT14 (0.54) KDRKMT2ASRCEGFRTEK
SCHEMBL23221981 0.81 JAK3 (0.48) JAK3NTRK1PIM1FLT3STK3
SCHEMBL3787081 0.80 SRC (0.50) KDRSRCABL1BRAFTNNI3K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070328-A1 MODULATORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY FOR USE IN THE TREATMENT OR PREVENTION OF SUBSTANCE ABUSE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-06-04 WO disclosed
EP-0888353-B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2003-07-09 EP disclosed
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed
EP-0888353-A1 NOVEL N-7-HETEROCYCLYL PYRROLO 2,3-D]PYRIDINES AND THEIR USE Novartis AG (CH) 1999-01-07 EP disclosed
WO-1997034895-A1 NOVEL N-7-HETEROCYCLYL PYRROLO[2,3-D]PYRIDINES AND THEIR USE NOVARTIS AG (CH) 1997-09-25 WO disclosed